scholarly journals A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD

2021 ◽  
Vol Volume 16 ◽  
pp. 3275-3284
Author(s):  
Juthaporn Cowan ◽  
Sunita Mulpuru ◽  
Sara J Abdallah ◽  
Anchal Chopra ◽  
Andrew Purssell ◽  
...  
Keyword(s):  
Feasibility Trial ◽  
Placebo Control ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Acute Exacerbations ◽  
Immunoglobulin Treatment

scholarly journals PD25 - Diagnostic specificity of symptoms seen in Double Blind Placebo Control Food Challenges (DBPCFCs). Do subjective symptoms lead to false positive test results and overdiagnosis?

2014 ◽  
Vol 4 (S1) ◽  
Author(s):  
Vasiliki-Lydia Sideridou ◽  
Bertine M Flokstra de Blok ◽  
Boudewijn J Kollen ◽  
Sicco van der Heide ◽  
Jeanet Kukler ◽  
...  
Keyword(s):  
False Positive ◽  
Placebo Control ◽  
Test Results ◽  
Subjective Symptoms ◽  
Diagnostic Specificity ◽  
Double Blind ◽  
Double Blind Placebo ◽  
False Positive Test ◽  
Control Food ◽  
Food Challenges

scholarly journals The role of G-CSF in recurrent implantation failure: A randomized double blind placebo control trial

2016 ◽  
Vol 14 (12) ◽  
pp. 737-742 ◽  
Author(s):  
Fatemeh Davari-tanha ◽  
Ensieh Shahrokh Tehraninejad ◽  
Mohadese Ghazi ◽  
Zahra Shahraki ◽  
◽  
...  
Keyword(s):  
Placebo Control Trial ◽  
Placebo Control ◽  
Implantation Failure ◽  
Recurrent Implantation Failure ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis

2019 ◽  
Vol 90 (5) ◽  
pp. 507-513 ◽  
Author(s):  
Shelly Coe ◽  
Jo Cossington ◽  
Johnny Collett ◽  
Andrew Soundy ◽  
Hooshang Izadi ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Potential Effect ◽  
Feasibility Trial ◽  
Walk Test ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Moderate Effect ◽  
Remitting Multiple Sclerosis ◽  
The Impact ◽  
Improve Fatigue

The impact of flavonoids on fatigue has not been investigated in relapsing and remitting multiple sclerosis (RRMS).ObjectiveTo determine the feasibility and estimate the potential effect of flavonoid-rich cocoa on fatigue and fatigability in RRMS.MethodsA randomised double-blind placebo-controlled feasibility study in people recently diagnosed with RRMS and fatigue, throughout the Thames Valley, UK (ISRCTN69897291). During a 6-week intervention participants consumed a high or low flavonoid cocoa beverage daily. Fatigue and fatigability were measured at three visits (weeks 0, 3 and 6). Feasibility and fidelity were assessed through recruitment and retention, adherence and a process evaluation.Results40 people with multiple sclerosis (10 men, 30 women, age 44±10 years) were randomised and allocated to high (n=19) or low (n=21) flavonoid groups and included in analysis. Missing data were <20% and adherence to intervention of allocated individuals was >75%. There was a small effect on fatigue (Neuro-QoL: effect size (ES) 0.04, 95% CI −0.40 to 0.48) and a moderate effect on fatigability (6 min walk test: ES 0.45, 95% CI −0.18 to 1.07). There were seven adverse events (four control, three intervention), only one of which was possibly related and it was resolved.ConclusionA flavonoid beverage demonstrates the potential to improve fatigue and fatigability in RRMS.

A Randomized Double-Blind Placebo-Control Study to Assess the Efficacy and Safety of OLNP-05 Versus Placebo for the Treatment of Subjects with Premature Ejaculation

2020 ◽  
Vol 23 (9) ◽  
pp. 1006-1013
Author(s):  
Sanjib Kumar Panda ◽  
Somashekara Nirvanashetty ◽  
Vivek A. Parachur ◽  
Nilima Mohanty
Keyword(s):  
Premature Ejaculation ◽  
Placebo Control ◽  
Efficacy And Safety ◽  
Placebo Control Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Control Study
Sign in / Sign up

Export Citation Format

Share Document